These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34464362)

  • 1. Diagnostic significance of stimulating growth factor ST2 and N-terminal prohormone of brain natriuretic peptide NT-PROBNP in patients with ischemic heart disease in the setting of metabolic syndrome.
    Shchurko M; Lapovets L; Bashta H; Lapovets N; Akimova V
    Pol Merkur Lekarski; 2021 Aug; 49(292):249-251. PubMed ID: 34464362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study.
    van den Berg VJ; Umans VAWM; Brankovic M; Oemrawsingh RM; Asselbergs FW; van der Harst P; Hoefer IE; Kietselaer B; Crijns HJGM; Lenderink T; Oude Ophuis AJ; van Schaik RH; Kardys I; Boersma E; Akkerhuis KM;
    Clin Chem Lab Med; 2020 Nov; 58(12):2099-2106. PubMed ID: 32383686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction].
    Gruzdeva OV; Akbasheva OE; Uchasova EG; Dyleva YA; Fedorova NV; Karetnikova VN; Kashtalap VV; Barbarash OL
    Ter Arkh; 2016; 88(4):9-15. PubMed ID: 27070156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 in stable and unstable ischemic heart diseases.
    Richards AM; Di Somma S; Mueller T
    Am J Cardiol; 2015 Apr; 115(7 Suppl):48B-58B. PubMed ID: 25678392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE ROLE OF NT-PROBNP AND ST2 BIOMARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROME.
    Barnett O; Halkevych M; Labinska O; Lutsiv N; Kyyak Y
    Wiad Lek; 2022; 75(1):34-38. PubMed ID: 35092243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases].
    Wei BQ; Zhang J; Yang YJ; Zhang YH; Huang XH; Yu LT; Zhou Q; Tan HQ; Yang YM; Wang GG; Zhu J
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(38):2683-7. PubMed ID: 22321977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes.
    Mady C; Fernandes F; Ramires FJ; Nastari L; Buck PC; Arteaga E; Ianni BM; Salemi VM
    Braz J Med Biol Res; 2008 Aug; 41(8):664-7. PubMed ID: 18797698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory indicators of pathological changes in patients with chronic heart failure with metabolic syndrome.
    Roytman AP; Sedova NA; Godkov MA
    Klin Lab Diagn; 2021 Mar; 66(2):75-79. PubMed ID: 33734639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
    Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
    Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
    Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
    Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between serum N-terminal pro-brain natriuretic peptide and metabolic syndrome: a cross-sectional study].
    Feng SQ; Ye P; Luo LM; Xiao WK; Xu RY; Wu HM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):130-4. PubMed ID: 23710744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.